Clinical study on efficacy of alendronate infusion for pediatric osteogenesis imperfecta (including severe form) Clinical study on efficacy of alendronateinfusion for pediatric osteogenesis imperfecta (including s ...
Clinical study on efficacy of alendronate infusion for pediatric osteogenesis imperfecta (including severe form) - Alendronate infusion for osteogenesis imperfecta Clinical study on efficacy of alendronateinfusion for pediatric osteogenesis imperfecta (including s ...
osteogenesis imperfecta
Eighteen micrograms (2 ml)/kg of alendronate will be infused in 1 hour every 4 weeks. The study duration is 6 months. When the patient's BMD reaches to the normal range for age, treatment with alendronate will be finished. When the patient's BMD does not reach to the normal range for age, alendronate will be continued for another 6 months. Eighteen micrograms (2 ml)/kg of alendronatewill be infused in 1 hour every 4 weeks. The study durat ...
Tohoku University School of Medicine, Department of Pediatrics
Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta
Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta: an Age Stratified Prospective Study Efficacy and Safety of Alendronatein Chinese Children or Adolescents With Osteogenesis Imperfecta: a ...